TG Therapeutics, Inc. (TGTX)
66.12
+3.41
(+5.44%)
USD |
NASDAQ |
Nov 18, 16:00
66.00
-0.12
(-0.18%)
After-Hours: 20:00
TG Therapeutics Price : 66.12 for Nov. 18, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 17, 2026 | 62.42 | 63.57 | 61.50 | 62.71 | 1.714M |
| Nov 16, 2026 | 64.69 | 65.34 | 62.02 | 62.76 | 1.732M |
| Nov 13, 2026 | 64.40 | 64.96 | 63.38 | 64.51 | 1.096M |
| Nov 12, 2026 | 65.76 | 65.86 | 63.28 | 64.56 | 1.581M |
| Nov 11, 2026 | 64.01 | 66.07 | 62.79 | 65.76 | 2.060M |
| Nov 10, 2026 | 62.70 | 68.03 | 62.00 | 64.26 | 5.791M |
| Nov 09, 2026 | 58.00 | 63.50 | 54.60 | 63.38 | 4.929M |
| Nov 06, 2026 | 57.99 | 60.82 | 57.55 | 59.82 | 2.306M |
| Nov 05, 2026 | 61.50 | 61.58 | 57.82 | 57.98 | 2.113M |
| Nov 04, 2026 | 61.85 | 62.78 | 60.31 | 61.63 | 2.040M |
| Nov 03, 2026 | 60.24 | 62.20 | 60.02 | 60.75 | 2.148M |
| Nov 02, 2026 | 61.01 | 63.60 | 59.59 | 59.95 | 2.576M |
| Oct 30, 2026 | 58.15 | 61.76 | 58.00 | 61.18 | 2.856M |
| Oct 29, 2026 | 57.81 | 58.96 | 56.93 | 58.08 | 1.789M |
| Oct 28, 2026 | 55.84 | 57.46 | 55.66 | 57.40 | 933755.0 |
| Oct 27, 2026 | 54.10 | 57.08 | 53.88 | 56.44 | 1.485M |
| Oct 26, 2026 | 54.81 | 55.49 | 53.71 | 54.79 | 1.187M |
| Oct 23, 2026 | 52.56 | 55.80 | 51.83 | 54.17 | 1.978M |
| Oct 22, 2026 | 53.02 | 53.70 | 52.53 | 53.16 | 1.289M |
| Oct 21, 2026 | 54.51 | 54.95 | 52.73 | 53.20 | 1.178M |
| Oct 20, 2026 | 53.36 | 55.32 | 53.08 | 54.53 | 1.058M |
| Oct 19, 2026 | 54.35 | 54.97 | 52.90 | 53.30 | 1.550M |
| Oct 16, 2026 | 56.00 | 56.24 | 53.66 | 53.97 | 1.773M |
| Oct 15, 2026 | 55.12 | 56.83 | 54.76 | 56.00 | 1.809M |
| Oct 14, 2026 | 54.08 | 55.37 | 53.36 | 54.37 | 1.286M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Amneal Pharmaceuticals, Inc. | 21.88 |
| Vertex Pharmaceuticals, Inc. | 536.32 |
| Arrowhead Pharmaceuticals, Inc. | 43.12 |
| Insmed, Inc. | 119.82 |
| Ionis Pharmaceuticals, Inc. | 27.38 |
Price Related Metrics
| PE Ratio | 98.19 |
| PS Ratio | 11.65 |
| Price to Book Value | 17.47 |
| Price to Free Cash Flow | 122.22 |
| Earnings Yield | 1.02% |
| Market Cap | 9.995B |
| Operating PE Ratio | 54.22 |
| Normalized PE Ratio | 91.68 |